These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31408289)

  • 1. Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL.
    Madhusoodanan V; Patel P; Lima TFN; Gondokusumo J; Lo E; Thirumavalavan N; Lipshultz LI; Ramasamy R
    Int Braz J Urol; 2019; 45(5):1008-1012. PubMed ID: 31408289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
    Reyes-Vallejo L; Lazarou S; Morgentaler A
    J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Non-Testosterone-Based Treatment in Hypogonadal Men: A Review.
    Raheem OA; Chen T; Akula KP; Greenberg J; Le TV; Chernobylsky D; Sikka SC; Walsh TJ
    Sex Med Rev; 2021 Jul; 9(3):381-392. PubMed ID: 33933392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
    Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
    J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Human Chorionic Gonadotropin Monotherapy for Men With Hypogonadal Symptoms and Normal Testosterone.
    Zucker I; Rainer Q; Pai RK; Ramasamy R; Masterson TA
    Cureus; 2022 May; 14(5):e25543. PubMed ID: 35800844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
    Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.
    Hsieh TC; Pastuszak AW; Hwang K; Lipshultz LI
    J Urol; 2013 Feb; 189(2):647-50. PubMed ID: 23260550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study.
    Habous M; Giona S; Tealab A; Aziz M; Williamson B; Nassar M; Abdelrahman Z; Remeah A; Abdelkader M; Binsaleh S; Muir G
    BJU Int; 2018 Nov; 122(5):889-897. PubMed ID: 29772111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogonadal symptoms in young men are associated with a serum total testosterone threshold of 400 ng/dL.
    Scovell JM; Ramasamy R; Wilken N; Kovac JR; Lipshultz LI
    BJU Int; 2015 Jul; 116(1):142-6. PubMed ID: 25345995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
    Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
    Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Testosterone Replacement Therapy on Penile Hemodynamics in Hypogonadal Men With Erectile Dysfunction, Having Veno-Occlusive Dysfunction.
    Efesoy O; Çayan S; Akbay E
    Am J Mens Health; 2018 May; 12(3):634-638. PubMed ID: 29575969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF
    Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Free Testosterone With Hypogonadal Symptoms in Men With Near-normal Total Testosterone Levels.
    Ramasamy R; Golan R; Wilken N; Scovell JM; Lipshultz LI
    Urology; 2015 Aug; 86(2):287-90. PubMed ID: 26199166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of hypogonadism and maintenance of fertility in men].
    Rabijewski M
    Pol Merkur Lekarski; 2016 Mar; 40(237):198-201. PubMed ID: 27088205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.